Citius Oncology
(NASDAQ) CTOR
Citius Oncology Financials at a Glance
Market Cap
$62.06M
Revenue (TTM)
$3.94M
Net Income (TTM)
$23.64M
EPS (TTM)
$-0.31
P/E Ratio
-2.28
Dividend
$0.00
Beta (Volatility)
-1.91 (Low)
Dividend
$0.00
Beta (Volatility)
-1.91 (Low)
Price
$0.71
Volume
7,662
Open
$0.71
Price
$0.71
Volume
7,662
Open
$0.71
Previous Close
$0.71
Daily Range
$0.71 - $0.79
52-Week Range
$0.49 - $6.19
Dividend
$0.00
Beta (Volatility)
-1.91 (Low)
Price
$0.71
Volume
7,662
Open
$0.71
Previous Close
$0.71
Daily Range
$0.71 - $0.79
52-Week Range
$0.49 - $6.19
CTOR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Citius Oncology
Industry
Biotechnology
Sector
Health CareCEO
Leonard L. Mazur, MBA
Website
citiusonc.comHeadquarters
New York City, NY 10170, US
CTOR Financials
Key Financial Metrics (TTM)
Gross Margin
80%
Operating Margin
-6%
Net Income Margin
-6%
Return on Equity
-47%
Return on Capital
-34%
Return on Assets
-21%
Earnings Yield
-43.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$62.06M
Shares Outstanding
88.28M
Volume
7.66K
Short Interest
0.00%
Avg. Volume
285.71K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$23.52M
EBITDA
$23.49M
Operating Cash Flow
$5.49M
Capital Expenditure
$4.00
Free Cash Flow
$5.49M
Cash & ST Invst.
$3.92M
Total Debt
$3.80M
Citius Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.94M
N/A
Gross Profit
$3.15M
N/A
Gross Margin
79.99%
N/A
Market Cap
$62.06M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$5.53M
+16.9%
EBITDA
$4.65M
+27.3%
Quarterly Fundamentals
Net Cash
$3.50M
+192.0%
Accounts Receivable
$4.05M
N/A
Inventory
$22.64M
+57.4%
Long Term Debt
$3.80M
+0.0%
Short Term Debt
$0.00
N/A
Return on Assets
-21.49%
N/A
Return on Invested Capital
-34.29%
N/A
Free Cash Flow
$7.35M
N/A
Operating Cash Flow
$7.35M
N/A